Tandem vs West Pharmaceutical Services
Side-by-side comparison of AI visibility scores, market position, and capabilities
Reached $1B valuation (2026). Automates specialty drug prior auth, access barriers, and copay assistance for providers. Targets $500B+ specialty drug access bottleneck.
About
Tandem is a specialty drug access automation platform that has reached a $1 billion valuation in 2026, providing AI-powered automation of the full specialty pharmaceutical access workflow for healthcare providers — prior authorization submissions, access barrier management, copay assistance enrollment, and patient assistance program identification. The platform targets the $500+ billion specialty drug market where access friction is the primary barrier preventing patients from receiving prescribed medications.
West Pharmaceutical Services (WST) reported ~$3.0B revenue in FY2024. Designs packaging components and delivery systems for injectable drugs — critical for vaccine and biologic drug manufacturing. HQ: Exton, PA.
About
West Pharmaceutical Services, Inc. is the global leader in packaging components and delivery systems for injectable medications, designing and manufacturing the stoppers, closures, caps, and drug delivery systems that seal vials, syringes, and cartridges containing vaccines, biologics, and injectable drugs. Every major pharmaceutical company and biologic manufacturer relies on West's containment solutions — the small rubber stopper sealing an mRNA vaccine vial or insulin cartridge is almost certainly a West product.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.